类风湿关节炎患者的运动锻炼方案

2022-08-17 风湿免疫科郑医生 风湿免疫科郑医生

运动和饮食一样,一直都是类风湿关节炎患者比较关心的话题。如果只依赖药物治疗,忽视关节功能锻炼的话,长期易导致关节活动度变小、肌肉无力和萎缩,造成关节功能障碍和生活质量下降,不利于关节功能恢复。

运动和饮食一样,一直都是类风湿关节炎患者比较关心的话题。如果只依赖药物治疗,忽视关节功能锻炼的话,长期易导致关节活动度变小、肌肉无力和萎缩,造成关节功能障碍和生活质量下降,不利于关节功能恢复。

那如何根据自身病情选择合适的运动项目和运动时长呢?2020年10月刚发布的《类风湿关节炎患者实践指南》,针对运动问题提出了详细的运动锻炼方案推荐意见。

建议类风湿关节炎患者注意适度运动。类风湿关节炎患者运动锻炼方式的具体选择应考虑多种因素,如年龄、体格、既往运动水平、疾病活动状态及是否存在关节结构性损伤等因素。因此在进行某项锻炼前,建议与医生共同讨论锻炼方式,争取较好的辅助治疗作用。

常推荐轻中度锻炼方式,如散步、游泳,尽量避免高强度负重运动及反复高冲击活动,如跑步和打球,并且以运动后不增加疼痛等疾病症状为原则。疾病缓解阶段建议类风湿关节炎患者也适度加强锻炼。具体的锻炼方案建议如下:

该运动方案是根据类风湿关节炎不同发展时期(如急性炎症期或高疾病活动状态、亚急性期和稳定期)给予不同的运动方式和强度推荐。

概况来说:

  • 急性期即高疾病活动时,要以休息为主,适度运动,如手、腕关节及四肢的被动和主动运动。

    (被动运动——腕关节屈伸运动,图片来源网络)

  • 关节肿痛等症状较前改善时,可适度增加训练,如从四肢的运动逐渐过渡到力量和有氧等动态锻炼。

  • 病情稳定期,即无明显关节肿痛时,可以选择中等强度锻炼并持之以恒。

◎可选择的运动方式有:

 手腕关节等关节活动锻炼、伸展运动、步行、太极、瑜伽、水上运动(含游泳,忌冷水)、骑行等。

◎运动强度和时间

  • 运动强度根据病情转归逐步增加,以运动后不加重疼痛或运动后疼痛不超过2小时为宜;

  • 运动时间从活动期的小量分次到稳定期的每周3~5次,每次30min,同样也是逐渐增加。

◎运动时要记住:

  • 最好是在开始任何锻炼计划之前寻求医生的建议;

  • 每次运动前要做一下热身动作;

  • 不要忘记小关节如手腕部关节功能活动度锻炼;

  • 不要过度运动;

  • 根据自身的疾病活动情况选择合适的运动方式、强度、时间,在症状严重的时候,可以减少锻炼强度;

  • 要长期坚持,不要盼望短时间内达到较好的康复;

  • 最后,请记住,尽管运动很重要,但避免不适或受伤也同样重要。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241834, encodeId=496812418346a, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Aug 29 14:35:59 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803987, encodeId=d09a180398ef9, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76169, encryptionId=62c7e6169ed, topicName=类风湿关节炎患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Oct 12 22:38:16 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266521, encodeId=61ae12665215f, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334420, encodeId=0af413344201d, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597454, encodeId=6f9c159e454d8, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2022-08-29 皮大叉

    11

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241834, encodeId=496812418346a, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Aug 29 14:35:59 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803987, encodeId=d09a180398ef9, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76169, encryptionId=62c7e6169ed, topicName=类风湿关节炎患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Oct 12 22:38:16 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266521, encodeId=61ae12665215f, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334420, encodeId=0af413344201d, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597454, encodeId=6f9c159e454d8, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1241834, encodeId=496812418346a, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Aug 29 14:35:59 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803987, encodeId=d09a180398ef9, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76169, encryptionId=62c7e6169ed, topicName=类风湿关节炎患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Oct 12 22:38:16 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266521, encodeId=61ae12665215f, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334420, encodeId=0af413344201d, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597454, encodeId=6f9c159e454d8, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2021-11-10 lmm397
  4. [GetPortalCommentsPageByObjectIdResponse(id=1241834, encodeId=496812418346a, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Aug 29 14:35:59 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803987, encodeId=d09a180398ef9, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76169, encryptionId=62c7e6169ed, topicName=类风湿关节炎患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Oct 12 22:38:16 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266521, encodeId=61ae12665215f, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334420, encodeId=0af413344201d, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597454, encodeId=6f9c159e454d8, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1241834, encodeId=496812418346a, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Aug 29 14:35:59 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803987, encodeId=d09a180398ef9, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76169, encryptionId=62c7e6169ed, topicName=类风湿关节炎患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Oct 12 22:38:16 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266521, encodeId=61ae12665215f, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334420, encodeId=0af413344201d, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597454, encodeId=6f9c159e454d8, content=<a href='/topic/show?id=fa1710082017' target=_blank style='color:#2F92EE;'>#风湿关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100820, encryptionId=fa1710082017, topicName=风湿关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456818510265, createdName=xuruicheng, createdTime=Wed Nov 10 00:38:16 CST 2021, time=2021-11-10, status=1, ipAttribution=)]

相关资讯

Stroke:药物相关性卒中

某些药物可能会增加缺血性卒中(ischemic stroke,IS)的风险。2021年10月来自葡萄牙的Jo?o Pedro Marto等在 Stroke 上发表了主题综述《药物相关性缺血性卒中》。该

Eur Urol:异时性转移激素敏感性前列腺癌男性中恩杂鲁胺和雄激素阻断疗法治疗的总生存率研究

在患有转移性激素敏感前列腺癌(mHSPC)的男性中,有着明确的临床亚组,且其预后各不相同。一个极端例子是在最初诊断时患有mHSPC的男性,如果只用睾酮抑制治疗,总生存期中位数约为3年。相比之下,最初出

BMJ:各国covid-19住院患者药物治疗大不相同

covid-19大流行的最初几个月使用了多种药物,有很大的地理和时间差异。羟基氯喹、阿奇霉素、洛匹那韦-利托那韦和umifenovir (仅在中国)是处方最多的改用药物。

BMJ:严重covid-19管理的进展与希望

对SARS-CoV-2感染的管理在继续演变。对于需要住院治疗的患者,死亡率可能很高(高达20%),但在大流行期间已经下降。死亡率取决于许多因素,我们学到了很多,但还有很多要学。

癫痫的鉴别诊断与药物治疗

癫痫是多种病因引起的慢性脑部疾病,脑神经元过度放电导致反复性、发作性和短暂性的中枢神经系统功能失常为特征。

口服抗病毒疗法全新临床试验结果发布:对所有新冠变种有效

日前,Atea Pharmaceuticals在2021年第二季度财报中公布了该公司和罗氏(Roche)联合开发的口服抗病毒疗法AT-527的最新临床试验结果。目前正在进行的2期临床试验的中期分析显示